5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Relapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-28NCT07686263
Efficacy of NBI-1117568 in Preventing Relapse in Adults With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-25NCT07227818
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 32026-09-25NCT07114874
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)Mania, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorderRecruitingPhase 32026-09-14NCT06929273
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotrigineBipolar and Related Disorders, Mania, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bipolar disorder, mood disorder, nervous system disorder, psychiatric disorderRecruitingPhase 32026-06-23NCT07140913